Eisai Co., Ltd. (FRA:EII)

Germany flag Germany · Delayed Price · Currency is EUR
24.31
+0.06 (0.25%)
Last updated: Jan 26, 2026, 8:34 AM CET
-13.98%
Market Cap6.63B -12.0%
Revenue (ttm)4.63B +6.8%
Net Income284.33M +20.5%
EPS1.01 +22.2%
Shares Outn/a
PE Ratio23.31
Forward PEn/a
Dividend0.95 (3.90%)
Ex-Dividend DateSep 29, 2025
Volumen/a
Average Volume129
Open24.31
Previous Close24.25
Day's Range24.31 - 24.31
52-Week Range21.45 - 31.41
Betan/a
RSI38.52
Earnings DateFeb 9, 2026

About Eisai

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan. [Read more]

Industry Pharmaceutical Preparations
Founded 1941
Employees 10,917
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol EII
Full Company Profile

Financial Performance

In fiscal year 2025, Eisai's revenue was 789.40 billion, an increase of 6.42% compared to the previous year's 741.75 billion. Earnings were 46.43 billion, an increase of 9.49%.

Financial numbers in JPY Financial Statements